Article
The genetic association of the transcription factor NPAT with glycemic response to metformin involves regulation of fuel selection.
PloS one - 1 Jan 2021
Chen Changwei, Gallagher Jennifer R, Tarlton Jamie, van Aalten Lidy, Bray Susan E, Ashford Michael L J, McCrimmon Rory J, Pearson Ewan R, McNeilly Alison D, Sutherland Calum
Abstract excerpt
The biguanide, metformin, is the first-choice therapeutic agent for type-2 diabetes, although the mechanisms that underpin metformin clinical efficacy remain the subject of much debate, partly due to the considerable variation in patient response to metformin. Identification of poor responders by genotype could avoid unnecessary treatment and provide clues to the underlying mechanism of action. GWAS identified...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
